MSX2 and osteopetrosis: Although compensation for RANKL loss of function could have potential as a therapy for osteopetrosis, but in Msx2−/− mice, this approach via RANK overexpression in monocyte-derived lineages, amplified latent epithelial tumor development in the peculiar continuously growing incisor.